L-carnitine ameliorates glycerol-induced myoglobinuric acute renal failure in rats

Renal Failure

Volumn 31, Issue 2, 2009, Pages 124-133

  Ustundag, Sedat ^a   Sen, Saniye ^a   Yalcin, Omer ^a   Ciftci, Senturk ^a   Demirkan, Bora ^a   Ture, Mevlut ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Acute renal failure; Iron; L carnitine; Myoglobin; Oxidative stress; Rhabdomyolysis

Indexed keywords

CARNITINE; CATALASE; CREATININE; ENZYME ACTIC; GLYCEROL; IRON; MALONALDEHYDE; N ACETYL BETA GLUCOSAMINIDASE; UNCLASSIFIED DRUG; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; MYOGLOBINURIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL PROTECTION; RHABDOMYOLYSIS; UREA BLOOD LEVEL;

ANIMALS; CARNITINE; GLYCEROL; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; MALONDIALDEHYDE; MYOGLOBINURIA; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN B COMPLEX;

EID: 61649089998     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802599130     Document Type: Article

References (38)

1. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 1996;49:314-326.
2. Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol. 2000;11:1553-1561.
3. Abassi ZA, Hoffman A, Better OS. Acute renal failure complicating muscle crush injury. Semin Nephrol. 1998;18:558-565.
4. Ustundag S, Yalcin O, Sen S, Cukur Z, Ciftci S, Demirkan B. Ren Fail. 2008;30:727-735.
5. Stefanovic V, Savic V, Vlahovic P, Cvetkovic T, Najman S, Mitic-Zlatkovic M. Reversal of experimental myoglobinuric acute renal failure with bioflavonoids from seeds of grape. Ren Fail. 2000;22:255-266.
6. Chander V, Chopra K. Molsidomine, a nitric oxide donor and L-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure. Biochim Biophys Acta. 2005;1723:208-214.
7. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 1984;74:1156-1164.
8. Emerit J, Beaumont C, Trivin F. Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother. 2001;55:333-339.
9. Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int. 1988;34:474-480.
10. Galaris D, Korantzopoulos P. On the molecular mechanism of metmyoglobin-catalyzed reduction of hydrogen peroxide by ascorbate. Free Radic Biol Med. 1997;22:657-667.
11. Di Lisa F, Barbato R, Manebo R, Siliprandi N. Carnitine and carnitine esters in mitochondrial metabolism and function. In: De Jong JW, Ferrari R, eds. The carnitine system. A new therapeutical approach to cardiovascular diseases. Dordrecth: Kluwer Academic Publishers; 1995:21-38.
12. Mayes PA. Lipids of physiologic significance. In: Murray RK, Granner DK, Mayes PA, Rodwell VW, eds. Harper's Biochemistry. Appleton and Lange: Stamford; 2000:160-171.
13. Arduini A. Carnitine and its acyl esters as secondary antioxidants? Am Heart J. 1992;123:1726-1727.
14. Gülçin I. Antioxidant and antiradical activities of L-carnitine. Life Sci. 2006;78:803-811.
15. Sener G, Ekşioǧlu-Demiralp E, Cetiner M, et al. L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death. Cell Biol Toxicol. 2006;22:47-60.
16. Boonsanit D, Kanchanapangka S, Buranakarl C. L-carnitine ameliorates doxorubicin-induced nephrotic syndrome in rats. Nephrology. 2006;11:313-320.
17. Origlia N, Migliori M, Panichi V, et al. Protective effect of L-propionylcarnitine in chronic cyclosporine-a induced nephrotoxicity. Biomed Pharmacother. 2006;60:77-81.
18. Görür S, Baǧdatoǧlu OT, Polat G. Protective effect of L-carnitine on renal ischaemia-reperfusion injury in the rat. Cell Biochem Funct. 2005;23:151-155.
19. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358.
20. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-126.
21. Shah SV, Walker PD. Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am J Physiol. 1988;255:F438-F443.
22. McHowat J, Yamada KA, Saffitz JE, Corr PB. Subcellular distribution of endogenous long chain acylcarnitines during hypoxia in adult canine myocytes. Cardiovasc Res. 1993;27:1237-1243.
23. Vanella A, Russo A, Acquaviva R, et al. L -propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol Toxicol. 2000;16:99-104.
24. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 1986;250:H822-H827.
25. Valdivielso JM, López-Novoa JM, Eleno N, Pérez Barriocanal F. Role of glomerular nitric oxide in glycerol-induced acute renal failure. Can J Physiol Pharmacol. 2000;78:476-482.
26. Alvarez de Sotomayor M, Bueno R, Pérez-Guerrero C, Herrera MD. Effect of L-carnitine and propionyl-L-carnitine on endothelial function of small mesenteric arteries from SHR. J Vasc Res. 2007;44:354-364.
27. Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: Role of iron in nephrotoxicity. Am J Physiol. 1988;255:F539-F544.
28. Calò LA, Davis PA, Pagnin E, et al. Carnitine-mediated improved response to erythropoietin involves induction of haem oxygenase-1: Studies in humans and in an animal model. Nephrol Dial Transplant. 2008;23:890-895.
29. Sever MS. The basic concepts. In: Sever MS, ed. The crush syndrome. Basel: Karger; 2005:15-35.
30. Rosenberger C, Goldfarb M, Shina A, et al. Evidence for sustained renal hypoxia and transient hypoxia adaptation in experimental rhabdomyolysis-induced acute kidney injury. Nephrol Dial Transplant. 2008;23:1135-1143.
31. Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet. 2003;42:941-967.
32. Bain MA, Faull R, Milne RW, Evans AM. Oral L-carnitine: metabolite formation and hemodialysis. Curr Drug Metab. 2006;7:811-816.
33. Reuter SE, Faull RJ, Evans AM. L-carnitine supplementation in the dialysis population: Are Australian patients missing out? Nephrology (Carlton). 2008;13:3-16.
34. Ohshima H, Kawabata T. Mechanism of N-nitrosodimethylamine formation from trimethylamine and trimethylaminoxide. IARC Sci Publ. 1978;19:143-153.
35. Simenhoff ML, Burke JF, Saukkonen JJ, Ordinario AT, Doty R. Biochemical profile or uremic breath. N Engl J Med. 1977;297:132-135.
36. Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci. 2004;1033:30-41.
37. Moretti S, Alesse E, Di Marzio L, et al. Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: A pilot study. Blood. 1998;91:3817-3824.
38. Moretti S, Famularo G, Marcellini S, et al. L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine. Antioxid Redox Signal. 2002;4:391-403.